- $18.55m
- -$50.77m
- $6.44m
Brief: Fibrogen Inc - On June 12 Enters Termination, Asset Transfer And License Agreement With Hifibio
Brief: Fibrogen Announces 1-For-25 Reverse Stock Split
Brief: Fibrogen Appoints Michael Kauffman To Its Board Of Directors
FibroGen Inc reports results for the quarter ended March 31 - Earnings Summary
FibroGen Inc expected to post earnings of 2 cents a share - Earnings Preview
FibroGen Inc expected to post earnings of 2 cents a share - Earnings Preview
FibroGen Inc reports results for the quarter ended December 31 - Earnings Summary
FibroGen Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: FibroGen Says Entered ATM Equity Offering Sales Agreement Relating To Sale From Time To Time Of Shares Of Common Stock
U.S. STOCKS ON THE MOVE-Repligen, Mangoceuticals, Insmed
U.S. STOCKS ON THE MOVE-Sabre, MicroStrategy, Repligen
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Roku, BioMarin, Assurant
FibroGen soars on $160 mln China unit sale to AstraZeneca
AstraZeneca to buy FibroGen's China unit for $160 million (updated)
FibroGen sells China unit to AstraZeneca in deal worth $160 million
Brief: Fibrogen Announces Sale Of Fibrogen China To Astrazeneca For About $160 Million
Brief: Fibrogen Appoints David Delucia As Chief Financial Officer
FibroGen Inc reports results for the quarter ended September 30 - Earnings Summary